Thus far the FDA has not approved a prescription drug specifically designed to fire up women’s sexual desire. According to ABCNews.com, a study in the early 2000s showed that postmenopausal and post-hysterectomy women taking 50-milligram Viagra pills reported “better overall sexual satisfaction” than those who got a placebo.
Meanwhile, Sprout Pharmaceuticals, the manufacturer of a drug called flibanserin, is continuing to press its application to have the FDA approve the drug for marketing as a treatment for HSDD (hypoactive sexual desire disorder), the most common form of female sexual dysfunction. Although the federal drug agency gave flibanserin a thumbs-down in late 2013, it did offer Sprout fairly clear-cut guidance about what additional testing would be necessary to keep the application alive. That testing is currently underway, and a revised application is expected to be filed in the third quarter of 2014.